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Abstract: 
 
Aim Colonoscopy to detect and remove polyps has contributed to a reduction in 
colorectal carcinoma. Three-year follow up is recommended for patients considered to be 
at high risk (at least three adenomas, adenoma ‡ 1 cm, villous or high-grade features). 
Our study focused on patients diagnosed with high-grade dysplasia with regard to initial 
management and follow up. 
 
Method A search of patients who had had endoscopic removal of a high-grade adenoma 
was carried out. Patients with the following were excluded: follow up of < 1 year, 
polyposis syndromes, prior colon cancer and a diagnosis of adenocarcinoma within 6 
months following initial diagnosis. 
 
Results Eighty-three patients treated between 1999 and 2007 for high-grade dysplasia 
(HGD) in a colorectal adenoma were identified. Over a median follow-up period of 4 
years, 53 (64%) developed further adenomatous polyps. Among these, 7% had an 
adenoma with HGD or an adenocarcinoma. In all these patients, the initial high-grade 
adenoma was > 1 cm in diameter. Initial follow-up colonoscopy was performed on 
average 7 months following the initial diagnosis. Ten per cent of patients underwent 
prophylactic segmental resection, and 6% received argon laser therapy. 
 
Conclusion The study demonstrates that patients who have a colorectal adenoma > 1 cm 
with HGD may be at high risk of developing further adenomas with HGD or carcinoma. 
Close follow up is warranted. 
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Introduction 
 
Adenomatous polyps are precursors of adenocarcinoma. Their number, size and histology 
provide the basis for recommended surveillance intervals [1]. Three-year follow 
up is recommended for patients with ‘advanced’ adenomas, including the presence of at 
least three adenomas, diameter ‡ 1 cm, those with villous morphology 
and high-grade dysplasia (HGD) [1]. Prospective studies have validated this 
recommendation, showing that although < 15% of patients fall into this category, 
metachronous adenoma formation in these cases exceeds 40% at 3 years [2]. Risk factors 
associated with HGD are similar to those used to define patients recommended for 3-year 
follow up, as well as other factors, including older age and not taking nonsteroidal anti-
inflammatory medication [3]. 
 
The clinical response to a diagnosis of adenoma with HGD has not been sufficiently 
evaluated [3–12]. Our study focused, therefore, on patients diagnosed with HGD with 
regard to initial management and subsequent follow up. 
 
The reporting of HGD in adenomas has been a topic of ongoing debate. Although current 
guidelines refer to HGD as a feature of advanced adenomas, no histological criteria have 
been provided to establish reporting guidelines [1]. Among reference pathology texts, the 
entity of HGD has not been clearly defined. The World Health Organization book on 
tumours of the digestive tract makes no mention of criteria for HGD, and the Armed 
Forces Institute of Pathology states that separations of low-grade dysplasia from HGD are 
superficial in nature because the two entities are part of a spectrum [13–15]. 
 
Histological definitions of HGD are essentially similar to adenomatous change with 
regard to cytological and architectural atypia, but more pronounced.  Histological 
features including a cribriform glandular architecture have been suggested by some 
groups to represent intramucosal carcinoma; however, this may still be classified as HGD 
by other pathologists [13]. The thresholds for diagnosing HGD and intramucosal 
carcinoma also vary according to country. The Japanese literature focuses on nuclear 
features, while Western pathologists place more emphasis on invasion through 
the muscularis mucosae [16]. This may account for the greater incidence of early 
carcinoma in the Japanese literature [16,17]. Despite diagnostic ambiguity and 
interobserver variability, HGD continues to be reported and influences patient 
management. An assessment of the prognosis for these patients is needed. This will help 
to define the role of HGD within the category of advanced adenoma to guide the clinical 
management. 
 
Method 
 
Following approval from the Institutional Review Board of Thomas Jefferson University 
Hospital, a search of the surgical pathology database was performed to identify 
cases of colorectal adenoma with a diagnosis of HGD (in our practice, low-grade 
dysplasia is not reported). The cases comprised a mixture of different polyp 
morphologies, including tubular and villous types. The percentage of HGD in each polyp 
was not evaluated, as this is not routinely carried out in pathology practice. Resection of 
the adenoma was complete in all patients, with no dysplastic mucosa remaining in the 
patient. Histological examination was performed on a minimum of three (range 3–9) 
transverse levels. 
 
Larger adenomas were oriented to show complete cross-sections from the apex to the 
cauterized base. Most of the cases were reviewed or signed out by one of the coauthors 
(JPP) to minimize interobserver variability. The endoscopic size, rather than gross 
measurement, was used to determine polyp dimensions. Microscopic features of 
HGD include enlarged, stratified nuclei with vesicular chromatin and nucleoli. Glandular 
branching, back-to-back glands and cribriforming are common, with occasional foci of 
necrosis. Our practice does not utilize the term intramucosal adenocarcinoma in isolation; 
however, this is sometimes used in conjunction with HGD (for example, patients may be 
diagnosed as HGD ⁄ intramucosal adenocarcinoma). Extension through the muscularis 
mucosae was used to diagnose invasive adenocarcinoma. 
 
Four hundred consecutive patients with a diagnosis of HGD from 1999 to 2007 were 
identified from chart and pathology database review. The following exclusion criteria 
were used: follow up of < 1 year, familial polyposis syndromes, previous history of colon 
cancer and a diagnosis of adenocarcinoma within 6 months following initial diagnosis 
(implying the diagnosis was a result of sampling error). After accounting for these, 83 
patients qualified for the study. Preanalytic variables, including demographics and polyp 
location ⁄ size, were collected. Initial therapeutic interventions were recorded, as were 
the colonoscopic intervals and neoplasm recurrence rate. A control population of 100 
consecutive patients with a diagnosis of tubular adenoma from 2000 were obtained 
using the same exclusion criteria, follow-up time and postpolypectomy recurrence 
markers. 
 
Statistical comparisons were performed using Fisher’s exact test for gender and race and 
Wilcoxon analysis for age. A P-value of < 0.05 was taken as being statistically 
significant. 
 
Results 
 
The results are summarized in Table 1. No statistically significant differences were 
identified in adenoma location. Villous architecture was seen in 53% of HGD cases 
(either villous or tubulovillous), and serrated features were noted in one case. Sixty-four 
per cent (53 of 83) of patients in the study group developed a metachronous 
adenoma at a median follow up of 4 (1.25–10) years. Among patients with a recurrent 
neoplasm, six (7%) developed an adenoma with HGD or an adenocarcinoma 
(five HGD, one adenocarcinoma). In all the six patients, the initial adenoma was > 1 cm 
in diameter. 
 
Follow-up colonoscopy was performed at an average of 7 (1–36) months following the 
initial diagnosis. The breakdown of the intervals was as follows: ￡ 6 months 
46.2%, 7–12 months 33.3%, 13–24 months 6.4%, and 25–36 months 14.1%. Ten per cent 
(n = 8) of patients underwent prophylactic segmental resection, 6% (n = 5) 
had endoscopic ultrasound, and 6% (n = 5) argon laser therapy. The average age of 
patients undergoing resection was 63.5 years, and argon therapy was 66 years. 
Three of the five patients having argon treatment chose this in preference to segmental 
resection. Among the eight patients who underwent segmental resection, three 
were felt to have an endoscopically unresectable adenoma owing to its large size or 
sessile morphology. Two cases were clinically regarded to be adenocarcinoma. 
Pathological examination of the resection specimen showed either residual adenoma or a 
scar, and none showed invasive adenocarcinoma. Among the control population 
of patients diagnosed with a tubular adenoma, 18 (18%) developed a metachronous 
adenoma; however, none showed HGD or adenocarcinoma. 
 
Discussion 
 
A colorectal adenoma with HGD larger than 1 cm in diameter may be a risk factor for 
metrachronous adenoma with HGD or ca    rcinoma. Over a period of 4 years, 7% of 
patients with a previous adenoma with HGD developed a recurrent adenoma with HGD 
or a carcinoma, compared with none in the control group. This finding is in agreement 
with previous studies of HGD [19,20]. Adenomas with HGD did not appear to have a 
particular endoscopic appearance. They were distributed throughout the colon, and 
although most were > 1 cm, 17% were < 1 cm. One of the larger studies of the prognostic 
significance of advanced adenomas included 1905 patients followed over 4 years. 
Villous histology was the only independent predictor of metrachronous advanced 
adenoma formation [3]. In the present study, 53% of the cases of adenoma found to 
have HGD were villous in type. 
 
In addition to focusing on HGD, our experience is the first from a single institution to 
assess the postpolypectomy management. Although based on consensus guidelines, 
management will continue to be individually tailored, and our study confirms the validity 
of this approach. Previous epidemiological studies have focused mainly on short- and 
long-term outcome, with little emphasis on the initial management. We found the 
diagnosis of HGD prompted earlier follow-up colonoscopy (mean 7 months) than would 
have been the case for adenomas not having HGD. There was also a high prevalence of 
invasive procedures, including argon laser therapy (6%) and prophylactic segmental 
resection (10%). Interventions during the follow up should also be guided by 
nonpathological factors, such as completeness of the polypectomy and the quality of the 
bowel preparation. Even after accounting for these, the diagnosis of HGD 
has a direct impact on management. 
 
Despite adherence to postpolypectomy surveillance guidelines, there remains a 
population of patients who develop colorectal adenocarcinoma during follow up 
[21]. While some of these may have had an adenoma missed during the initial 
colonoscopy, there remains a significant population of true ‘interval’ cancers. Our study 
attempted to control for lesions missed at the index colonoscopy by excluding patients 
diagnosed with invasive adenocarcinoma within 6 months following it. Furthermore, 
we controlled for interobserver variability by using a control population and by having a 
single specialist pathologist (JPP) review the cases of HGD. While the term ‘advanced 
adenoma’ is useful to describe general features which increase the risk of carcinoma, it is 
difficult to apply in individual cases. High-grade dysplasia identifies a subset of patients 
falling into the category of advanced adenoma that require close follow up. From the 
standpoint of pathological reporting, our study confirms that both HGD and villous 
architecture should continue to be routinely reported. Future research focusing on the 
identification of molecular markers which may predict recurrence of HGD and the 
development of adenocarcinoma would greatly assist the gastroenterologist in 
managing these patients. 
 
A close working relationship between the gastroenterologist and pathologist is needed to 
ensure that the clinician understands the pathological findings and appreciates the varying 
threshold for diagnosing HGD. 
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